Skip to content

Clinical trials

Pulmonary Embolism trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Country / region: Russia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20063
20074
20091
20131
20142
20163
20173
20191
20202
20212
20221
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting6
Unknown status3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pirogov Russian National Research Medical University5
Bristol-Myers Squibb4
Bayer3
Daiichi Sankyo3
Meshalkin Research Institute of Pathology of Circulation2
Supergene, LLC2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Eurasian Association of Therapists1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism30
Venous Thrombosis20
Venous Thromboembolism13
Thrombosis6
COVID-193
Thromboembolism3
Arrhythmias, Cardiac2
Atrial Fibrillation2
Cardiovascular Diseases2
Embolism and Thrombosis2

Trials

Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.